Jumonji Domain Containing Protein 3 (JMJD3) As a Novel Epigenetic Mechanism of Fibroblast Activation By Regulation of Fra-2

Bergmann C, Brandt A, Dees C, Zhang Y, Lin NY, Chen CW, Mallano T, Liang R, Kam PS, Distler O, Schett G, Distler J (2016)

Publication Type: Conference contribution

Publication year: 2016

Journal

Arthritis and Rheumatology Wiley

Book Volume: 68

Authors with CRIS profile

Adrian Brandt Lehrstuhl für Arbeits-, Sozial- und Umweltmedizin Clara Dees Department of Medicine 3 – Rheumatology and Immunology Yun Zhang Department of Medicine 3 – Rheumatology and Immunology Tatjana Mallano Department of Medicine 3 – Rheumatology and Immunology Ruifang Liang Professur für Molekulare und Experimentelle Chirurgie Georg Schett Lehrstuhl für Innere Medizin III Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

Universitätsspital Zürich (USZ) CH Switzerland (CH)

How to cite

APA:

Bergmann, C., Brandt, A., Dees, C., Zhang, Y., Lin, N.-Y., Chen, C.-W.,... Distler, J. (2016). Jumonji Domain Containing Protein 3 (JMJD3) As a Novel Epigenetic Mechanism of Fibroblast Activation By Regulation of Fra-2.

MLA:

Bergmann, Christina, et al. "Jumonji Domain Containing Protein 3 (JMJD3) As a Novel Epigenetic Mechanism of Fibroblast Activation By Regulation of Fra-2." 2016.

BibTeX: Download